Avoiding unnecessary biopsy in suspicious prostate cancer using PRIMARY score ≤3 and PSAD ≤0.2 ng/mL/cm3: a real-world, dual-center study from China

International Journal of Surgery 2026 Open access

Read full text

Authors: Jiawei He, Lin Qi, Minfeng Chen, Shuo Hu, Xiaomei Gao, Yongxiang Tang, Shouzhen Chen, Yi Cai

DOI: 10.1097/js9.0000000000004733

Cited by: 2

References: 29

Abstract

BACKGROUND: Among Chinese men with prostate-specific antigen (PSA) 4-20 ng/mL scheduled for biopsy,

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Medical Imaging Techniques and Applications

References 29